US equities |
NVDA $238.38 ▲+1.90% SPCX $167.69 ▲+5.49% MU $1,063.13 ▼-1.09% TSLA $379.43 ▲+2.39% MSFT $525.16 ▲+1.47% SNDK $1,711.06 ▼-0.52% INTC $117.01 ▼-1.94% META $742.70 ▲+2.01%
FinancialContent

Vistagen Therapeutics, Inc. - Common Stock (NQ:VTGN)

0.2709 -0.0101 (-3.59%)
Delayed Quote Updated: 2:16 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vistagen Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Notifies Vistagen (VTGN) Investors of the Pending Class Action Lawsuit
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) DEADLINE ALERT – Bernstein Liebhard LLP Reminds Vistagen Therapeutics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Why Did Vistagen Stock Tank 82% Today? ↗
Via Stocktwits
News headline image
Earnings Scheduled For November 13, 2025 ↗
 
Via Benzinga
News headline image
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
VTGN Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Vistagen Therapeutics, Inc. Securities Class Action Lawsuit
From Robbins LLP
Via GlobeNewswire
News headline image
VISTAGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Rosen Law Firm Urges Vistagen Therapeutics, Inc. (NASDAQ: VTGN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
VISTAGEN THERAPEUTICS, INC. (NASDAQ: VTGN) INVESTOR ALERT Investors With Large Losses in Vistagen Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Vistagen Therapeutics
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Investor Notice: Robbins LLP Informs Investors of the Vistagen Therapeutics, Inc. Securities Class Action
From Robbins LLP
Via Business Wire
News headline image
These stocks have an unusual volume in today's session ↗
Let's explore the current happenings on the US markets on Monday. Below, you'll find the stocks exhibiting unusual volume in today's session. 
Via Chartmill
News headline image
On Friday, there are stocks with unusual volume. Let's take a look. ↗
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
News headline image
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
Let's have a look at the stocks with an unusual volume in today's session. 
Via Chartmill
News headline image
Vistagen Announces Topline Results from PALISADE-3 Phase 3 Public Speaking Challenge Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
From Vistagen
Via Business Wire
News headline image
Vistagen Appoints Nick Tressler as Chief Financial Officer
From Vistagen
Via Business Wire
News headline image
Vistagen Reports Findings on PH80’s Brain and Autonomic Effects in Women with Menopausal Hot Flashes at The Menopause Society 2025 Annual Meeting
From Vistagen
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Vistagen (VTGN) Q2 2026 Earnings Call Transcript ↗
Vistagen (VTGN) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Vistagen Reports Fiscal Year 2026 Second Quarter Financial Results and Provides Corporate Update
From Vistagen
Via Business Wire
News headline image
Examining the Future: VistaGen Therapeutics's Earnings Outlook ↗
 
Via Benzinga
News headline image
Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen to Participate in Stifel Healthcare Conference 2025
From Vistagen
Via Business Wire
News headline image
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder
From Vistagen
Via Business Wire
News headline image
Vistagen Appoints Paul Edick to its Board of Directors
From Vistagen
Via Business Wire
News headline image
Vistagen to Present at The Menopause Society 2025 Annual Meeting
From Vistagen
Via Business Wire
News headline image
Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
From Vistagen
Via Business Wire
News headline image
Vistagen (VTGN) Q1 R&D Expense Jumps 54% ↗
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >